Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
CanSino Biologics Yönetim
Yönetim kriter kontrolleri 4/4
CanSino Biologics' CEO is Xuefeng Yu, appointed in Jan 2009, has a tenure of 15.75 years. total yearly compensation is CN¥3.97M, comprised of 64.1% salary and 35.9% bonuses, including company stock and options. directly owns 11.96% of the company’s shares, worth HK$1.29B. The average tenure of the management team and the board of directors is 6.7 years and 3 years respectively.
Anahtar bilgiler
Xuefeng Yu
İcra Kurulu Başkanı
CN¥4.0m
Toplam tazminat
| CEO maaş yüzdesi | 64.1% |
| CEO görev süresi | 15.8yrs |
| CEO sahipliği | 12.0% |
| Yönetim ortalama görev süresi | 6.7yrs |
| Yönetim Kurulu ortalama görev süresi | 3yrs |
Son yönetim güncellemeleri
Recent updates
Should Shareholders Worry About CanSino Biologics Inc.'s (HKG:6185) CEO Compensation Package?
Jun 20
The Consensus EPS Estimates For CanSino Biologics Inc. (HKG:6185) Just Fell Dramatically
Apr 07Is CanSino Biologics (HKG:6185) Weighed On By Its Debt Load?
Feb 06CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?
Oct 13Analysts Are More Bearish On CanSino Biologics Inc. (HKG:6185) Than They Used To Be
Sep 07CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?
May 12Does CanSino Biologics (HKG:6185) Have A Healthy Balance Sheet?
Jan 09CanSino Biologics Inc.'s (HKG:6185) Share Price Not Quite Adding Up
Sep 16Things Look Grim For CanSino Biologics Inc. (HKG:6185) After Today's Downgrade
Aug 31Should You Be Adding CanSino Biologics (HKG:6185) To Your Watchlist Today?
Aug 29Analysts Just Made A Major Revision To Their CanSino Biologics Inc. (HKG:6185) Revenue Forecasts
Jul 13Is CanSino Biologics (HKG:6185) Using Too Much Debt?
Jul 01We Think CanSino Biologics (HKG:6185) Can Stay On Top Of Its Debt
Mar 15CanSino Biologics Inc. (HKG:6185) Analysts Just Slashed Next Year's Revenue Estimates By 15%
Jan 11CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥867m |
| Mar 31 2024 | n/a | n/a | -CN¥2b |
| Dec 31 2023 | CN¥4m | CN¥3m | -CN¥1b |
| Sep 30 2023 | n/a | n/a | -CN¥1b |
| Jun 30 2023 | n/a | n/a | -CN¥2b |
| Mar 31 2023 | n/a | n/a | -CN¥1b |
| Dec 31 2022 | CN¥5m | CN¥2m | -CN¥909m |
Tazminat ve Piyasa: Xuefeng's total compensation ($USD563.98K) is about average for companies of similar size in the Hong Kong market ($USD564.92K).
Tazminat ve Kazançlar: Xuefeng's compensation has been consistent with company performance over the past year.
CEO
Xuefeng Yu (59 yo)
15.8yrs
Görev süresi
CN¥3,965,000
Tazminat
Dr. Xuefeng Yu, Ph D, is Co-Founder of CanSino Biologics Inc. since 2009. Dr. Yu serves as an Executive Director at CanSino Biologics Inc. since January 13, 2009 and has served as its Chief Executive Offic...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder | 15.8yrs | CN¥3.97m | 11.96% CN¥ 1.3b | |
| Co-Founder | 15.8yrs | CN¥4.42m | 7.27% CN¥ 782.4m | |
| Co-Founder | 15.8yrs | CN¥3.74m | 11.42% CN¥ 1.2b | |
| COO, Deputy GM & Executive Director | 6.4yrs | CN¥3.93m | 0.0081% CN¥ 871.6k | |
| Chief Commercial Officer | 3.1yrs | CN¥4.57m | 0.0072% CN¥ 775.9k | |
| Senior Director of New Technology Department | 6.9yrs | Veri yok | Veri yok | |
| Vice President of Marketing | no data | Veri yok | Veri yok | |
| Board Secretary | 5.6yrs | Veri yok | Veri yok | |
| Joint Company Secretary | 5.6yrs | Veri yok | Veri yok |
6.7yrs
Ortalama Görev Süresi
51yo
Ortalama Yaş
Deneyimli Yönetim: 6185's management team is seasoned and experienced (6.7 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder | 15.8yrs | CN¥3.97m | 11.96% CN¥ 1.3b | |
| COO, Deputy GM & Executive Director | 6.3yrs | CN¥3.93m | 0.0081% CN¥ 871.6k | |
| Chief Commercial Officer | 3yrs | CN¥4.57m | 0.0072% CN¥ 775.9k | |
| Co-Chair of Scientific Advisory Board | 1.8yrs | Veri yok | Veri yok | |
| Independent Non-Executive Director | 4.9yrs | CN¥300.00k | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Chairman of Employee Representative Supervisor | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | 4.9yrs | CN¥300.00k | 0.00040% CN¥ 43.0k | |
| Co-Chair of Scientific Advisory Board | 1.8yrs | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of the Scientific Advisory Board | 2.4yrs | Veri yok | Veri yok | |
| Independent Non-Executive Director | no data | Veri yok | Veri yok |
3.0yrs
Ortalama Görev Süresi
59yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 6185 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3 yıldır).